SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety said on Monday.
South Korea restored tough distancing curbs last week after easing them in November, after a series of record daily new infections and serious cases stretched medical services, despite a vaccination rate of over 92% for those aged 18 or older.
Already a subscriber? Log in.
Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!